12-7064316-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_001734.5(C1S):c.441C>T(p.Cys147=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0772 in 1,613,732 control chromosomes in the GnomAD database, including 5,437 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.094 ( 774 hom., cov: 32)
Exomes 𝑓: 0.075 ( 4663 hom. )
Consequence
C1S
NM_001734.5 synonymous
NM_001734.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.914
Genes affected
C1S (HGNC:1247): (complement C1s) This gene encodes a serine protease, which is a major constituent of the human complement subcomponent C1. C1s associates with two other complement components C1r and C1q in order to yield the first component of the serum complement system. Defects in this gene are the cause of selective C1s deficiency. [provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 12-7064316-C-T is Benign according to our data. Variant chr12-7064316-C-T is described in ClinVar as [Benign]. Clinvar id is 402439.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-7064316-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.914 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.144 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C1S | NM_001734.5 | c.441C>T | p.Cys147= | synonymous_variant | 5/12 | ENST00000360817.10 | NP_001725.1 | |
C1S | NM_201442.4 | c.441C>T | p.Cys147= | synonymous_variant | 5/12 | NP_958850.1 | ||
C1S | NM_001346850.2 | c.-61C>T | 5_prime_UTR_variant | 4/11 | NP_001333779.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C1S | ENST00000360817.10 | c.441C>T | p.Cys147= | synonymous_variant | 5/12 | 1 | NM_001734.5 | ENSP00000354057 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0941 AC: 14298AN: 152018Hom.: 772 Cov.: 32
GnomAD3 genomes
AF:
AC:
14298
AN:
152018
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0779 AC: 19589AN: 251466Hom.: 904 AF XY: 0.0790 AC XY: 10730AN XY: 135906
GnomAD3 exomes
AF:
AC:
19589
AN:
251466
Hom.:
AF XY:
AC XY:
10730
AN XY:
135906
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0755 AC: 110334AN: 1461596Hom.: 4663 Cov.: 31 AF XY: 0.0762 AC XY: 55402AN XY: 727116
GnomAD4 exome
AF:
AC:
110334
AN:
1461596
Hom.:
Cov.:
31
AF XY:
AC XY:
55402
AN XY:
727116
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0941 AC: 14318AN: 152136Hom.: 774 Cov.: 32 AF XY: 0.0932 AC XY: 6930AN XY: 74360
GnomAD4 genome
AF:
AC:
14318
AN:
152136
Hom.:
Cov.:
32
AF XY:
AC XY:
6930
AN XY:
74360
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
245
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 04, 2021 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at